World Stroke Organization 
Learning Objectives:
- Understand Cerebral Small Vessel Disease risk factors and their impact on pathophysiology
- Recognize Cerebral Small Vessel Disease neuroimaging and its relevance for patient outcomes
- Evaluate drug and lifestyle approaches for Cerebral Small Vessel Disease management.
Scientific Program:
- Chair Introductions, Bo Norrving
- Epidemiology, risk factors & pathophysiology, Christopher Chen
- Neuroimaging and clinical implications, Simon Frandler-Höfler
- Pharmacological and lifestyle interventions, Joanna Wardlaw
- Q&A Discussion, moderated by Anna Bersano
- Closing Remarks, World Stroke Academy
Date and Time: November 16th, 3pm (CET)
Webinar Details
Speakers:
- Prof. Joanna Wardlaw, Chair of Applied Neuroimaging and Head of Neuroimaging Sciences and Edinburgh Imaging, University of Edinburgh, UK
- Prof. Christopher Chen, Associate Professor, Department of Pharmacology, Yong Loo Lin School of Medicine, National University of Singapore
- Dr. Simon Fandler-Höfler, Neurologist, Department of Neurology, Medical University of Graz, Austria
Moderator:
- Dr. Anna Bersano, Director of Cerebrovascular Diseases Istituto Neurologico C. Besta, Italy
- Prof. Bo Norrving, Professor in Neurology, Lund University, Sweden
;
